Latest news

Press release May 17, 2010
AXL1717 clinical data from ongoing phase I/II study in
cancer patients will be released in connection with the
ASCO meeting in Chicago, June 2010

Press release April 27, 2010
Axelar’s board strengthened

Press release November 13, 2009
Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, Massachusetts, USA

Press release May 06, 2009
Successful Phase I/II Clinical Trial Results from Cancer Patients Treated with Anticancer Drug from Axelar AB

Press release June 17, 2008
Axelar initiates phase I/II clinical trial on cancer patients with the new anti-cancer drug AXL1717

Press release June 12, 2008
Axelar receives financing for a phase I/II clinical trial on cancer patients with the new anti-cancer drug AXL1717